What are the payment terms?

We accept T/T, LC, and D/P as terms of payment.

How long is the delivery time?

The average lead time is one month for both peak season and off-season orders.

Hormones Medicine Levonorgestrel Tablet 1.5mg

Name: Hormones Medicine Levonorgestrel Tablet 1.5mg
Brand: Anhui Medipharm Co., Ltd.
SKU: 1942414851

Anhui, ChinaAnhui Medipharm Co., Ltd.

US$0.287

20,000 Pieces

Sample price:US$0.00/piece.Request sample

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

For oral administration

Model NO.

AMC12078-01

Suitable for

Adult

State

Solid

Shape

Tablet

Type

Biological Products

Pharmaceutical Technology

Chemical Synthesis

Transport Package

1's Box

Specification

1.5mg

Trademark

Shinepharm/OEM

Origin

China

HS Code

300490909

Production Capacity

1000000 Boxes/Month

Key features

High Efficacy: Effectiveness increases when taken as soon as possible after intercourse.

Proven Quality Standards: Assay results at 99.7%, dissolution at 89.1%, meeting strict compliance.

Trusted Manufacturer: Over 15 years of experience exporting to 60+ countries globally.

Customization Available: Full customization options available from designs and samples.

ISO Certified: Manufacturing process certified under ISO45001:2018 and ISO14001.

Fast Delivery: Average lead time of one month for both peak and off-season orders.

Competitive Pricing: Offers good quality products with competitive prices for customers.

Company profile

Years of Export ExperienceHigh Repeat Buyers ChoiceImporters and ExportersManagement Certification

Anhui Medipharm Co., Ltd.

Anhui, China

Business Type: Manufacturer/Factory, Trading Company CertifiedR&D Capacity: ODM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 14 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤3.00h

AI-Powered supplier vetting

SummaryAnhui Medipharm Co., Ltd. is a China-based trading company established in 2010 with 32 employees and a broad healthcare-related product scope. It has overseas agents or branches, participated in the 136th Canton Fair, and exports 90% of total sales, but no overseas showroom is reported. Service procedures, corrective and preventive action procedures, and complaint-handling procedures are documented and supported by records. The supplier reports ISO9001:2015, ISO45001:2018, and ISO14001 certifications, although it lacks a factory environmental impact assessment report. Innovation and customization are supported by recent new products, ODM services, and multiple customization methods. Production capability is not demonstrated because the supplier is identified as a trading company and no manufacturing capacity is provided. Financial information only identifies reporting years, without substantive performance data. No specific customer cases are provided.

Supplier typeThe supplier is identified as a trading company or trade company, organized as a limited company in Hefei, Anhui, China, with 32 employees. Its listed product scope covers medicines, veterinary drugs, nutritional and medical products, additives, APIs, and related categories, indicating broad trading coverage rather than confirmed in-house manufacturing.

CertificationsThe supplier reports ISO9001:2015, ISO45001:2018, and ISO14001 certifications. However, it also reports no factory environmental impact assessment report; this does not negate the stated certifications but indicates incomplete environmental documentation for factory-related assessment.

After-Sales capabilityThe supplier has overseas agents or branches, has participated in the 136th Canton Fair, and serves listed markets including Papua New Guinea and Cameroon. Written procedures and records exist for service assessment, corrective and preventive actions, and customer complaints, while stated peak- and off-season lead times are both one month.

R&D capabilityThe supplier reports launching new products during the past year and provides ODM services, supporting active product development. It does not provide an SDK and does not offer OEM services for well-known brands, so the evidence supports product innovation but not software-development or major-brand OEM capability.

Customization capabilityThe supplier reports customization from designs, customization from samples, and full customization, as well as ODM service availability. These statements explicitly support a broad customization offering, although the evidence does not quantify capacity or specify production ownership.